Curvebeam AI Ltd. (AU:CVB) has released an update.
CurveBeam AI Ltd. has successfully issued 11,111,111 new shares at $0.18 each to KP Rx Healthcare Opportunities Fund as part of its second tranche of institutional placement. This move is a strategic effort to bolster its capital, supporting the company’s ongoing development of cutting-edge medical imaging technology. The newly issued shares will have the same rights as existing shares, signaling a promising step for investors interested in the company’s growth trajectory.
For further insights into AU:CVB stock, check out TipRanks’ Stock Analysis page.